Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.8430 per EA under NDC 59651097360. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on May 14, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651097360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208039FDA Approved
5/14/2025
TE Code
AB
On Market Since
5/14/2025
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8430 per EA |
|---|---|
| All-time high | $1.0929 (Jan 14, 2026) |
| All-time low | $0.8430 (Aug 19, 2026) |
| 52-week high | $1.0929 |
| 52-week low | $0.8430 |
| Median price | $0.9204 |
| Average price | $0.9510 |
| Largest weekly change | -10.0% (Apr 22, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Aurobindo Pharma Limited, is $0.8430 per EA (NDC 59651097360), effective Aug 19, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 22.9%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Dec 17, 2025, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8430 (Aug 19, 2026) to a high of $1.0929 (Jan 14, 2026), with a median of $0.9204 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 75 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 59651097360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.